Paragon 28 (FNA) Competitors

Inspire Medical Systems (NYSE:INSP) and Paragon 28 (NYSE:FNA) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, community ranking, institutional ownership, earnings, analyst recommendations, valuation and dividends.

Which has more risk and volatility, INSP or FNA?

Inspire Medical Systems has a beta of 1.39, indicating that its share price is 39% more volatile than the S&P 500. Comparatively, Paragon 28 has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500.

Which has stronger earnings and valuation, INSP or FNA?

Inspire Medical Systems has higher revenue and earnings than Paragon 28. Paragon 28 is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Medical Systems	$802.80M	5.84	$53.51M	$1.73	91.09
Paragon 28	$256.18M	4.29	-$57.53M	-$0.63	-20.80

Does the media prefer INSP or FNA?

In the previous week, Inspire Medical Systems had 12 more articles in the media than Paragon 28. MarketBeat recorded 21 mentions for Inspire Medical Systems and 9 mentions for Paragon 28. Inspire Medical Systems' average media sentiment score of 0.93 beat Paragon 28's score of 0.71 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspire Medical Systems	11 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
Paragon 28	3 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer INSP or FNA?

Inspire Medical Systems currently has a consensus price target of $218.90, indicating a potential upside of 38.91%. Paragon 28 has a consensus price target of $14.20, indicating a potential upside of 8.36%. Given Inspire Medical Systems' stronger consensus rating and higher probable upside, equities analysts plainly believe Inspire Medical Systems is more favorable than Paragon 28.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Medical Systems	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70
Paragon 28	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Is INSP or FNA more profitable?

Inspire Medical Systems has a net margin of 6.67% compared to Paragon 28's net margin of -25.31%. Inspire Medical Systems' return on equity of 8.19% beat Paragon 28's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspire Medical Systems	6.67%	8.19%	7.09%
Paragon 28	-25.31%	-37.90%	-18.22%

Does the MarketBeat Community prefer INSP or FNA?

Inspire Medical Systems received 160 more outperform votes than Paragon 28 when rated by MarketBeat users. However, 74.47% of users gave Paragon 28 an outperform vote while only 61.71% of users gave Inspire Medical Systems an outperform vote.

Company	Underperform	Outperform
Inspire Medical Systems	Outperform Votes 195 61.71%	Underperform Votes 121 38.29%
Paragon 28	Outperform Votes 35 74.47%	Underperform Votes 12 25.53%

Do institutionals and insiders believe in INSP or FNA?

94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 63.6% of Paragon 28 shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by insiders. Comparatively, 15.3% of Paragon 28 shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Inspire Medical Systems beats Paragon 28 on 15 of the 18 factors compared between the two stocks.